A detailed history of Gamma Investing LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 605 shares of AURA stock, worth $4,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
605
Previous 1,662 63.6%
Holding current value
$4,198
Previous $9.74 Million 61.12%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

SELL
$4.9 - $6.97 $5,179 - $7,367
-1,057 Reduced 63.6%
605 $3.79 Million
Q1 2025

Apr 14, 2025

SELL
$5.86 - $8.45 $47,331 - $68,250
-8,077 Reduced 82.93%
1,662 $9.74 Million
Q1 2025

Apr 07, 2025

BUY
$5.86 - $8.45 $56,097 - $80,891
9,573 Added 5766.87%
9,739 $1.66 Million
Q4 2024

Jan 02, 2025

BUY
$8.11 - $11.74 $1,143 - $1,655
141 Added 564.0%
166 $1.37 Million
Q3 2024

Oct 04, 2024

BUY
$6.9 - $10.36 $172 - $259
25 New
25 $223,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $203M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.